(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Address

10197 N 92nd St, Suite 101
Scottsdale, AZ 85258
P: (480) 993-2950

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.